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With continuing advances in the burgeoning field of electronic brachytherapy, an 
accurate method of 3D dosimetry is needed to ensure understanding of dose distributions, 
which can improve patient care. The aim of this study was to characterize the Xoft Axxent 
electronic brachytherapy source using PRESAGETM dosimeters in order to obtain 
independent confirmation of TG-43U1 dosimetry values, as well as to further add to the 
literature of both Xoft and PRESAGE. 
PRESAGE is a polyurethane-based solid 3D dosimeter doped with a radiochromic 
leuco dye which produces a linear change in optical density when exposed to radiation. 
This optical density change is imaged using an optical-CT scanner and reconstructed for 
analysis using MATLAB software. A Xoft source with a measured air kerma strength of 
126095 U was used in this experiment to irradiate 8 PRESAGE dosimeters to 15 Gy at 1 
cm in order to evaluate the dose rates from r=1 cm to r=5 cm. The dosimetric parameters 
were calculated and compared to the Rivard et al. (1)(1) parameters.  
In general, the measured results closer to the source more closely matched the 
comparison data than those values measured further from the source. The radial dose 
function was within 6% of the expected values, and the anisotropy function, ignoring the 
extreme outlier at each radius, was within 35% of the expected values. An incorrect shutter 
value was used when imaging the dosimeters so that the post-irradiation scans were 
repeated 2 months after the irradiation, allowing time for the dosimeter to darken as it aged, 
which increased background noise, and time for the dose signal to fade, thereby bringing 
the dose signal closer to the background noise. The experiment should be repeated to 
obtain more accurate results.  
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1 Introduction 
1.1 Statement of Problem 
1.1.1 General Problem Area 
With advances in radiotherapy technology leading to the delivery of more conformal 
doses to smaller treatment volumes (2, 3), quality assurance (QA) of such delivery and 
equipment has become more important. Currently, 1D and 2D QA methods are used to 
sample dosimetric data in 3D volumes. Dosimetry is performed so the radiation dose given 
to a patient can be accurately measured, but this is innately a 3D problem, wherein the 
radiation interacts with atoms within the patient’s body in all directions, and should therefore 
have a 3D method of measurement. 1D and 2D systems have been used effectively, but 
can have volume average, artifacts, and energy dependence. The advantage of 3D 
dosimetry is that a complete dose distribution can potentially be measured in a single 
irradiation; this is impractical for TLD irradiations, and film only provides one plane at a 
time. 3D dosimetry can conceivably save the physicist valuable time. 
The need for a 3D dosimeter is accentuated when considering brachytherapy, or 
short range therapy, where small radioactive sources are placed directly within the 
treatment site, creating sharp dose fall-off regions. The dose in these regions is difficult to 
measure accurately using conventional dosimetry systems. For example, it is difficult to 
accurately measure steep dose gradients using 1D dosimeters such thermoluminescence 
dosimeters, due to their finite size and volume-averaging effects(4); and some 2D 
dosimeters such as film are subject to artifacts from handling, dependence on energy, and 
possibly dependence on dose rate (at the extrema of dose and dose rate) (5). Dose 
measurements are required to characterize brachytherapy sources for patient treatment-
planning calculations.  
1.1.2 Specific Problem Area 
PRESAGETM is a new type of 3D dosimeter which addresses some of the problems 
of 1D and 2D dosimeters(6) mentioned above. PRESAGE has been used to determine 
dose distributions from a linear accelerator(6), low dose rate (LDR) brachytherapy 
sources(7), as well as high dose rate (HDR) brachytherapy sources(8).   
In the last decade, a new electronic brachytherapy source, Xoft Axxent (Xoft, Inc., a 
subsidiary of iCAD, San Jose, CA) has been studied for use in partial breast irradiation 
(PBI) treatments for breast cancer. Xoft has also been studied for use in skin treatments 
and in vaginal cancer treatments as a replacement for 192Ir(9). Although many Xoft 
applications have been studied since its introduction (10-12), there is only one published 
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paper that provides TG-43U1 dosimetry data for the source (1). PRESAGE has not yet 
been used to characterize this new HDR system.  
1.2 Background 
1.2.1 Brachytherapy 
Brachytherapy, or short range radiotherapy, is a method of radiation treatment 
wherein a radioactive source is placed in or near a tumor and the radiation from the 
decaying source causes damage to the tumor cells, often while sparing more surrounding 
normal tissue than external beam radiotherapy (13). Generally, brachytherapy uses sealed 
radioactive sources, radioactive material encapsulated within a metal wall, to deliver this 
form of treatment. It can be delivered interstitially, inside a cavity (intracavitary), or to the 
surface of a patient. Cancers that are commonly treated with brachytherapy are skin, 
breast, prostate, vaginal, cervix, and eye.(14) 
There are advantages to brachytherapy over external beam radiotherapy. First, 
brachytherapy involves placement of sources in or close to the target tissue, maximizing the 
tumor dose and minimizing the dose to surrounding normal tissue. Second, brachytherapy 
has a lower dose rate when compared to external beam radiotherapy.  The lower dose rate 
can be exploited, as will be explained below.    
Brachytherapy was first performed with radium sources, and later, radon, cobalt, 
tantalum, gold, and americium. Today, these sources have been replaced by cesium, 
iodine, iridium, and palladium (15). Brachytherapy, using the various isotopes, will either be 
classified as low dose rate (LDR) or high dose rate (HDR) depending on the ICRU 
definition. The International Commission on Radiation Units (ICRU) and Measurements 
Report 38 (16) defines three main categories of dose rate: high, medium, and low, as 
described in Table 1.  
 
Dose Rate Category Dose Rate (Gy/hr) 
Low Dose Rate (LDR) .04 - 2 
Medium Dose Rate (MDR) 2 - 12 
High Dose Rate (HDR) >12 
Table 1. Dose rate categories from ICRU Report 38 (16) 
Table 2 contains the most commonly used radioisotopes in each dose rate category, along 
with their dose rate, half-life, and gamma-ray energy range.  
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Isotope Dose Rate Half-life γ-ray Energy 
241Am LDR 432.2 years 13.9-59.5 keV 
137Cs HDR/LDR 30.0 years 662 keV 
60Co HDR/LDR 5.26 years 1.17-1.33 MeV 
198Au LDR 2.7 days 0.41-1.09 MeV 
125I LDR 59.4 days 35.5 keV 
192Ir HDR/LDR 73.8 days 0.14-1.06 MeV 
103Pd LDR 17.0 days 20-22.7 keV 
226Ra LDR 1622 years 0.05-2.4 MeV 
222Rn LDR 3.83 days 0.05-2.4 MeV 
182Ta LDR 115 days 0.04-1.45 MeV 
Table 2. Common brachytherapy radionuclides and their characteristics (14, 15) 
LDR brachytherapy involves placement of sources within or adjacent to the tumor 
for an extended period of time, often several days and in some cases, permanently.  The 
low dose rate allows normal tissue to perform repair during the treatment, in contrast with 
fractionated external beam therapy where repair takes place between treatment fractions.  
At the same time, however, the continuous dose delivery allows the total dose, or a large 
fraction of the dose, to be delivered in a shorter elapsed time, thereby minimizing tumor 
repopulation effects.  
In contrast, HDR brachytherapy combines the shorter overall treatment time and 
dose localization capabilities of LDR brachytherapy with the benefits of hypofractionated 
external beam therapy. With HDR, normal cells have time between treatment fractions to 
repair sublethal damage. (13)  
AAPM TG-43U1(17) discusses how to calculate the dose from brachytherapy 
sources, and AAPM TG-56 (18) discusses how to calibrate brachytherapy sources. TG-
43U1 will be discussed in detail in Chapter 2, and TG-56 will be briefly explained here for 
the most common HDR source, 192Ir. The HDR iridium source has no national standard; 
however, an interpolation can be made between 137Cs and orthovoltage energies. As an 
interim standard, the interpolative free air secondary standard method is now accepted. 
(19) To perform this calibration, air kerma rate measurements are taken along the z-axis of 
the source from 10 to 100 cm away with an ion chamber in a free air geometry. (Section 2.4 
and Figure 21 provide a detailed description of the TG-43U1-defined coordinate system.) 
The ion chamber should have a buildup cap thick enough to ensure secondary electron 
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equilibrium. The 192Ir air kerma calibration factor is derived by interpolating between the 
137Cs and orthovoltage air kerma factors, which are Accredited Dosimetry Calibration 
Laboratory (ADCL) or National Standards Institute of Technology (NIST) traceable. It 
should be noted that this calibration procedure is not recommended to be performed by 
clinical medical physicists, but rather by the trained calibration laboratory personnel. This 
procedure is only noted here for comparison with the Xoft Axxent calibration procedure.  
Both AAPM TG-56 and AAPM TG-59 (20) discuss how to perform a standard HDR 
treatment. This is discussed here very generally, again, for comparison with a Xoft Axxent 
electronic brachytherapy treatment. An HDR source is at the end of a long wire, which is 
kept within the shielded afterloader. The patient is setup with the catheter in place, within 
the appropriate applicator, as is applicable to the treatment. The personnel leave the room 
and operate the afterloader from outside the treatment vault. When the treatment begins, 
the source, on its wire, moves out of the afterloader and down into the catheter, and into the 
patient. Various dwell positions and dwell times of the HDR source, as determined with the 
treatment planning system (TPS) to achieve the desired dose to the tumor, are controlled 
by the HDR console during treatment.  
1.2.2 Electronic brachytherapy 
In response to complicated intraoperative radiotherapy procedures and 
requirements, as well as the inconvenience of dealing with radioactive materials regulations 
and security requirements, small, mobile, low kV x-ray sources were developed in the late 
1990s. (21) These sources have since been co-opted by the brachytherapy community. 
Their low energy x-rays greatly minimized exposure to the staff, though their usage is 
currently limited to small tumors. The Xoft Axxent system was ostensibly developed to 
mimic the treatment energies of HDR 192Ir so it could be directly substituted into many 
current cancer treatment techniques. 
AAPM TG-61 (22) covers low energy x-ray calibration and dosimetry. This is 
typically used for superficial and orthovoltage machines, but, the Xoft User’s Manual (22) 
states that it should be applied in the interim while an AAPM task group report is being 
prepared on electronic brachytherapy. Low kV x-ray calibrations should be traceable to a 
national standard, either NIST or an ADCL, and are performed in air, to obtain the air kerma 
strength. 
1.2.2.1 Xoft 
Xoft Axxent is an electronic brachytherapy system that consists of an electronic 
controller, a miniature electronic x-ray source inside a flexible catheter (shown in Figure 1), 
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and a balloon applicator. The x-ray tube inside the catheter is water-cooled with sterile 
water; the x-ray tube inside the catheter is shown in Figure 2. The catheter is 250 mm in 
length and 5.1-5.4 mm in diameter. (23)  
 
 
Figure 1. Xoft Axxent source in its shipment box. 
 
 
Figure 2. Drawing of inside the Xoft catheter.(1) 
The Xoft source can deliver dose at voltages of 40 kV, 45 kV, and 50 kV. The 
average energy of the Xoft spectrum at 50 kV is 26.6-26.7 keV. The dose rate is expected 
to be 0.6 Gy/min at 3 cm from the source axis. 
The power requirement for the Xoft Axxent device is 15 W. The maximum beam 
current is 300 µA, but is adjustable for treatment. The x-ray tube can be stepped to different 
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dwell positions within the catheter at millimeter intervals and for different dwell times, just as 
conventional HDR sources can be. The manufacturer recommends that each Xoft source is 
disposed of after whichever of the following occurs first: 10 fractions, 170 minutes of 
treatment time, or 35 days after the initial calibration, provided the cooling water is 
vacuumed out after each use. (24) All sources are disposable. The Xoft system complies 
with the International Electrotechnical Commission (IEC) medical electrical safety 
equipment standard 60601-2-17. (25) 
 
 
Figure 3. Xoft Axxent electronic brachytherapy system controller (24) 
Both BrachyVision and Plato TPS have been verified for use with the Xoft Axxent 
electronic brachytherapy source. If an electrical malfunction occurs during the treatment, as 
mandated by the IEC (25), the controller, shown in Figure 3, will stop the treatment and 
record the treatment values at that time. The display shows dwell position, and total 
planned time, elapsed time, and time left at current dwell position; the display screen, as 
part of the system controller, is shown in Figure 3.  
Air kerma strength is measured by the manufacturer prior to shipment, and again by 
the physicist prior to each fraction. Before each clinical treatment, the air kerma strength of 
the source is measured and compared to the “nominal” air kerma strength, which was 
determined when the system was initially calibrated and is used to create treatment plans. 
A ratio of the “nominal” to the measured air kerma strength is used to adjust the dwell times 
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in the TPS. The air kerma strength is measured in the attached Standard Imaging well 
chamber and electrometer (Models HDR 1000 Plus and MAX-4000, respectively (Standard 
Imaging, Middleton, WI)) using a custom insert that attenuates the source. The purpose of 
this insert is threefold: 1) it shields the source so personnel may remain in the treatment 
room while calibrating, 2) it absorbs the lower energy photons that would be absorbed in 
the applicator during treatment, and 3) it reduces the source output so it is within the 
operating range of the electrometer. This well chamber, insert, and electrometer system 
must be calibrated by an ADCL every two years.  
The well chamber calibration for this source has no NIST standard procedure; 
however, the ADCL at the University of Wisconsin (UW) developed a secondary calibration 
method combining methodology described in both TG-43U1 and TG-61 (Report 79) on low 
energy x-ray dosimetry. The calibration coefficient for the well chamber is based on a 
comparison of the I-125 national standard and the measurement of the Xoft Axxent source 
using an Attix free-air chamber (FAC) at the UWADCL (University of Wisconsin Accredited 
Dosimetry Calibration Laboratory). First, a well chamber calibration coefficient C is obtained 
for I-125, resulting in air kerma strength per corrected well chamber current unit (U/A). Next, 
the output of the Xoft source is measured in the FAC, and then in the well chamber; a 
calibration coefficient is obtained for Xoft. The ratio R is defined as the ratio of the Xoft 
calibration coefficient to C, the I-125 well chamber calibration coefficient. C times R results 
in NSK, or the air kerma strength well chamber calibration coefficient for Xoft. This is the 
“nominal” SK used in the TPS; SK is air kerma strength in U, and its full TG-43U1 definition 
is provided in Chapter 2. The manual describes a “compensated” air kerma strength value, 
which is the air kerma strength corrected for temperature and pressure. (24) 
Each patient receives their own disposable Xoft source. To deliver a treatment, the 
source is connected to the high voltage and water-cooling systems, calibrated in the well 
chamber, then finally inserted into the applicator in the patient. The operator may stay in the 
room during the treatment, due to the low energy nature of the x-rays produced by the Xoft 
source. This is an advantage to treating with Xoft. For example, for a breast cancer 
treatment, a 0.4 mm lead equivalent shield placed over the patient’s breast will reduce 
exposure from 15 mR/h to 1 mR/h at the operator’s location. However, the resulting 
scattered radiation will increase the dose to the patient. To further reduce exposure, 
personnel may wear lead-equivalent aprons. This also drastically reduces the room 
shielding requirements. (23) 
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TG-152 (publication date unknown) has been assigned to address clinical 
application and quality assurance procedures for electronic brachytherapy sources, 
including the Xoft Axxent system.  
1.2.2.2 Previous Xoft Studies 
Xoft has been studied as an alternative accelerated partial breast irradiation (APBI) 
method (10, 26), in nonmelanoma skin cancer treatment (12), and in endometrial cancer 
treatment (10). These studies were performed to compare Xoft with the current accepted 
treatment method, the 192Ir HDR source, in effectiveness and dose coverage. There have 
been poster displays describing the Xoft dosimetry as determined using MOSFET(27), film 
(28, 29), ion chambers(29), an x-ray spectrometer(29), and solid and liquid water (30), as 
well as Monte Carlo simulations (30-32), but the Rivard et al. paper (1) is the only published 
source that provides the TG-43U1 dosimetry parameters. It should be noted that these 
posters were all done in part by a Xoft employee, and so technically violate the TG-43U1 
recommendation that “independent and redundant dosimetric characterizations” be 
performed for every new brachytherapy source intended for clinical use. 
Rivard et al. used both Monte Carlo simulations and liquid water measurements with 
a PTW parallel plate ionization chamber to characterize the source.  The Monte Carlo 
simulations were based on the MCNP5 code and the EPDL97-based mcplib04 cross-
section library.  TG-43U1 parameters (radial dose function, anisotropy function) were 
determined for radial distances between 0.4 cm and 15 cm, and angles between 0° and 
175°.  Ion chamber measurements were made many locations corresponding to the 
calculation points.  Operating voltages of 40 kV, 45 kV and 50 kV were used for simulations 
and measurements. The Rivard et al. data was used to create the Xoft User’s Manual. 
Characterizing the Xoft source with PRESAGE is a novel experiment, and would add 
independently-derived dosimetry data to the existing body of knowledge. A better 
understanding of Xoft dosimetry can be used to more accurately treat patients.  
1.2.3 PRESAGE Dosimeters 
1.2.3.1 Gel Dosimetry 
PRESAGE (Heuris Pharma LLC) was introduced in 2003 as an alternative to gel 
dosimeters. Gel dosimetry was first explored in the 1950s; the first radiosensitive gels were 
doped with a dye and would change color due to a chemical reaction when exposed to 
radiation. The next type of gel dosimeter was doped with chloral hydrate, which reacted to 
radiation; the change in the gel could be observed using pH probe measurements or 
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spectrophotometry. In the 1980s, the chemical reaction to radiation in Fricke gels, which 
were doped with ferrous sulfate, could be imaged with an MRI machine.   
Another type of gel dosimeter, now more common, is the polymer gel dosimeter, 
which would polymerize as a function of dose when exposed to radiation. The 
polymerization could be measured using MRI, optical-CT, x-ray CT, or ultrasound. BANANA 
(made of bis-acrylamide in an aqueous agarose matrix, nitrous oxide, and agarose) and 
BANG (made of bis-acrylamide in an aqueous agarose matrix, nitrogen, and aqueous 
gelatin) gels are examples of polymer gels. The optical-CT scanner developed for use with 
these gels was a precursor to the optical-CT scanner used in this project. (33) 
There are drawbacks to using gel dosimeters. First, they are oxygen-sensitive; 
oxygen inhibits the polymerization process. Polymer gels must be manufactured and stored 
in an oxygen-free environment, which is not practical in a clinical setting. Next, gels must be 
stored in a container, but imaging the container results in edge artifacts, even when steps 
are taken to minimize these effects via refractive index matching fluid. In Fricke gels, 
diffusion of the ions caused a loss of spatial resolution and an unstable dose distribution. 
Other types of gels do not have the same diffusion issue. Lastly, when using optical-CT to 
image gel dosimeters, light scatter artifacts become an issue. PRESAGE addresses these 
issues, as explained in the next section. (34)  
1.2.3.2 Characteristics of PRESAGE 3D Dosimeters 
When exposed to radiation, PRESAGE dosimeters produce an optical density 
change that can be imaged with an optical-CT to determine dose. A PRESAGE dosimeter, 
as seen in Figure 4, is a polyurethane-based dosimeter that is doped with leucomalachite 
green (LMG) dye which reacts linearly to radiation dose, regardless of photon energy and 
dose rate. (6) Halocarbon free radical initiators respond to high energy radiation, and in so 
doing, oxidize the LMG, creating the change in OD. The sensitivity of the dosimeter 
depends on the type of halogens used in the initiator. (35) The oxidation of the LMG dye 
creates a stable signal in PRESAGE. However, some current experimental formulations of 
PRESAGE are attempting to create a reusable dosimeter and so do not allow a lasting 
stable signal. Different PRESAGE formulations are made to be more sensitive to different 
types of radiation, e.g., photons versus protons.  
- 
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Figure 4. Example of an irradiated solid 1 kg PRESAGE dosimeter. 
PRESAGE was created so the user can acquire a 3D volume of data from a single 
irradiation. PRESAGE is imaged using an optical-CT scanner, which provides the user with 
the optical density changes in the dosimeter which are used to determine dose. (6) The 
resolution of PRESAGE depends on the resolution of the scanner used to image it (see 
section 1.2.3.2 for more information). Its effective Z is ~7.7, which closely mimics that of 
soft tissue or water (Zeff ~ 7.4, in both cases). The density of PRESAGE is 1.05 g/cm3, 
which compares well with that of water. (36) PRESAGE, unlike gel dosimeters, is not 
oxygen sensitive and requires no external container. With PRESAGE, there is no diffusion 
of the dye, and it can be synthesized into different shapes and sizes.  PRESAGE is, 
however, light and heat sensitive. 
Although PRESAGE is currently best used as a relative dosimeter, an absolute dose 
calibration curve can be created for each batch of PRESAGE using cuvettes containing the 
PRESAGE material. The cuvettes are irradiated to a range of doses, then the optical 
density (OD) is read out. A graph of OD change versus dose in Gy is created and can be 
used to scale the larger PRESAGE dosimeters from that batch to an absolute dose. The 
calibration curve illustrates that the change in OD is linear with dose. The calibration curve 
can account for signal changes post-irradiation; it has been shown that the “standard” 
formulation signal can fade by 4% per 24-hour post-irradiation period. (6) With a slightly 
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different formulation (the “soft” batch), this signal fading can be accelerated, so that a 
dosimeter would be bleached and reusable after a week. Current research in this direction 
is ongoing. 
1.2.3.3 Drawbacks of PRESAGE 
PRESAGE is sensitive to UV and blue light (35). To prevent this sensitivity, 
PRESAGE is stored in black, light-tight bags when not in use. Scanning and irriadiating is 
performed with the lights out. PRESAGE is also sensitive to temperature. This issue is dealt 
with by storing PRESAGE in a refrigerator kept at 4° C. For the entire pre-irradiation scan, 
irradiation, post-irradiation scan process, it is recommended that the PRESAGE be kept at 
room temperature for accurate dosimetry. (6, 37) 
1.2.3.4 Optical-CT Imaging with DMOS 
The optical-CT scanner used at the Imaging and Radiation Oncology Core in 
Houston (IROC-Houston, formerly the Radiological Physics Center (RPC)) is called DMOS 
(Duke Medium-field-of-view optical-CT scanner) and it is shown in Figure 5. The 
configuration of the scanner is as follows: a diffuse red LED light shines through the 
dosimeter, which is placed in an indexing tank, and on through a lens into a CCD camera. 
The aquarium is filled with a mix of octyl salicylate, octyl cinnamate, and light mineral oil to 
match the refractive index of the dosimeter at the fluid-dosimeter interfaces; this helps 
prevent dosimeter edge effects that blur the optical density signal. (38) The LMG dye used 
in PRESAGE was chosen, in part, because its visible absorbance maximum corresponds to 
the 633 nm red laser light that was used to optically scan PRESAGE in the first 
commercially-available optical-CT scanner. (6) The DMOS has a red LED light of the same 
wavelength. 
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Figure 5. Diagram of DMOS system's main components. 
The dosimeter rotates via an electronic stepper motor base. The lens rejects stray 
light that is further than 0.1° off the optical axis. The camera takes line integrals at each 
projection angle, which are used to reconstruct a 3D image via filtered backprojection. 
LabView is used to collect the images and rotate the dosimeter. An example of the DMOS 
Acquisition GUI (Duke University, NC) is shown in Figure 6. The user enters the filename 
stem, the file destination, and the scanning parameters. (39) The total scan time for a 1 kg 
dosimeter is between 15 and 20 minutes. This is a vast improvement on the first 
commercially available optical-CT scanner mentioned previously, which took 7 minutes per 
z slice, for a total scan time of a few hours. (40) 
Dosimeters are scanned prior to and after irradiation so that background and final 
OD can be determined. In general, 720 projection images are taken, one every 0.5°; 8 
images are averaged together at each projection angle. A flood image is taken without a 
PRESAGE dosimeter in the aquarium to correct for inhomogeneities in both the matching 
fluid and LED light field. A dark image is taken to correct for electronic noise. Both the flood 
and dark images are 200 averages of one projection image.  
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Figure 6. Screenshot of DMOS Acquisition GUI without a dosimeter in the tank. 
The spatial resolution of the system depends on user settings and available storage 
space for the projection images. Typically, the dosimeters at IROC-Houston are scanned to 
have either 0.5 mm or 1 mm voxels. The resolution of PRESAGE can only be as high as 
the resolution of the scanner used to image it. The CCD Basler camera captures 12-bit 
monochromatic 1040x1392 pixel arrays.  
Monochromatic light attenuates exponentially under narrow beam conditions, as 
exist in the DMOS. The optical-CT readout of a dose response in PRESAGE is explained 
by this 2D, i.e., per projection angle, equation:  
 𝐼(𝑥) = 𝐼0𝑒
− ∫ 𝜇(𝑥,𝑦)𝑑𝑦 Eqn. 1 
Here, I0 is the incident intensity of the light hitting the dosimeter, I(x) is the intensity of the 
light exiting the dosimeter at position x, and µ(x, y) is the optical attenuation coefficient per 
unit length. (33) From this equation, we can calculate the OD, or absorbance, of the 
dosimeter with this equation:  
 𝑂𝐷 =  − log (𝐼 𝐼0
⁄ ) (7) Eqn. 2 
This is what is calculated and saved in the 3D data cube matrix output from the 
Reconstruction software. From the OD, the dose can be calculated, either by the cuvette 
calibration curve, or the following equation:  
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 𝐷𝑜𝑠𝑒 =  −
𝑂𝐷
𝑠 ×  𝑥
 Eqn. 3 
where OD is defined previously, s is the sensitivity (∆OD/Gy/cm) and x is the irradiated path 
length in cm. If relative dose is all that is needed, the data cube is normalized to a user-
specified dose delivered at a user-specified location. 
Reconstruction of the projection images is completed using the DMOS software; a 
screenshot of the Reconstruction GUI is shown in Figure 7. First, the pre-irradiation and 
post-irradiation optical-CT scan images are each loaded together with a flood image and a 
dark image to make the corresponding corrections for background noise. To create the 
sinogram, a 5x5 kernel median filter is applied to reduce noise, and a 1 mm voxel size is 
selected for reconstruction. As part of this process, the pre-irradiation scan image is 
subtracted from the post-irradiation scan image to obtain a net change in the dosimeter. In 
the end, a series of 2D sinograms is generated.  
A sinogram is a single image of all the raw data acquired by the CT scanner; an 
example sinogram can be seen in the top right corner of Figure 8. The horizontal axis of the 
sinogram represents each angle at which a projection image was taken; for this experiment, 
a projection image was taken every 0.5° from 0° to 360°. The vertical axis of the sinogram 
represents the projection images taken; 720 projection images were taken in this 
experiment. Filtered backprojection (FBP) is an iterative reconstruction technique which 
uses the sinogram to reconstruct a 3D tomographic image of the original scanned object; it 
is the “computed” in CT’s computed tomography.   
To perform FBP, the backprojection is completed first. Backprojection reverses the 
image acquisition steps, taking the linear optical attenuation coefficient µ for each 
projection, and “smearing” it back along the angle at which the projection image was taken 
into its position in an empty image matrix; backprojection will fill the image matrix. In this 
manner, the high attenuation areas reinforce each other, as do the low attenuation areas, 
creating a 3D reconstructed image representation of the original object scanned. A filter is 
applied to correct the 1/r blurring caused by reconstructing an image using 
backprojection.(41)  
The DMOS Reconstruction GUI, seen in Figure 7, reconstructs the final 3D optical-
CT image of the dosimeter via filtered backprojection; the “iradon” function in MATLAB 
performs the backprojection, and the RAM LAK filter smoothes out the blurriness (42). The 
user selects the center of rotation (COR) to reconstruct around, and the size of the data 
cube in mm, which should be slightly larger than the physical dosimeter size. The final 3D 
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“image” is saved as a data cube, which is the input for the radial and anisotropy data 
extraction scripts. (39)  
 
 
Figure 7. Screenshot of the DMOS Reconstruction GUI. 
  
1.2.3.5 Previous work with PRESAGE 
PRESAGE has been used to check IMRT dose distributions, and was found to be 
accurate to within 3%/3mm when evaluating dose distributions using the gamma index. (43) 
A gamma index comparison between EBT film, PRESAGE, and software-calculated dose 
distributions found three-way agreement to be within 4%/4mm. (40) An investigation of 
PRESAGE to measure doses  in the RPC head and neck (H&N) phantom yielded 
acceptable results; a gamma index comparison between Eclipse, PRESAGE, and EBT was 
within 4%/4mm for that experiment (44). PRESAGE has been investigated for use with 
radiosurgery treatment systems; Niebanck found less than 3% standard deviation of dose in 
the target (3) and Clift et al. measured scatter factors in PRESAGE that agreed with ion 
chamber measurements within 4% for every field (45). PRESAGE has also been 
investigated as a new way to perform IMRT QA, with a 94.9% passing rate for a 3%/2mm 
gamma index. (46) PRESAGE was used to obtain TG-43 dosimetric parameters for the 192Ir 
source, with a percentage of standard deviation between PRESAGE and published results 
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of 2.6% or less. (8) This will be the first time PRESAGE has been used to characterize an 
electronic brachytherapy source. 
1.3 Hypothesis and Specific Aims 
We hypothesize that PRESAGE dosimeters can measure, with 95% confidence, the 
AAPM TG-43U1 dosimetric parameters of the Xoft Axxent electronic brachytherapy source, 
to within 5% and 3mm of published values. 
The specific aims for testing this hypothesis: 
1. Write code specifically for use with PRESAGE dosimeters in MATLAB to extract 
data for TG-43U1 analysis.  
2. Determine the TG-43U1 parameters of the Xoft Axxent electronic brachytherapy 
source using PRESAGE dosimeters. TG-43U1 parameters will be extracted from the optical 
scans of the irradiated dosimeters via the code developed in Specific Aim 1. 
3. Compare PRESAGE-measured TG-43U1 parameters for the Xoft Axxent 
electronic brachytherapy system with published parameters.  
2 Methods & Materials 
2.1 Dosimeter Design 
Two formulations of PRESAGETM were irradiated with the Xoft source - a "soft" 
batch (#46), and a "hard" batch (#45. According to the manufacturer, the difference 
between the two formulations is the polyurethane used - soft versus hard. The soft batch is 
more tissue-equivalent, but will bleach over time (a new experimental formula), and the 
hard dosimeters are the usual PRESAGE formulation. The dosimeters are approximately 1 
kg, 12 cm in height, and 11 cm in diameter. Due to the size of the DMOS tank and the field-
of-view of the DMOS camera, the dosimeters cannot be much larger than this. The size of 
the dosimeters also limits the maximum radius to which the dose can be measured to 
approximately 5 cm. 
Both formulations of PRESAGE were cast with two different channel sizes, as seen 
in Figures 8-9. The two channel sizes were first suggested by Olivia Huang's research 
using AgX100 I-125 seeds (7). She found that because PRESAGE reacts linearly to dose, a 
large dose near the source will cause a great change in OD, such that when the dosimeter 
is optically CT-scanned, imaging through the center becomes difficult since the dye is so 
dark there. However, if the dosimeter is irradiated with the source in a PRESAGE plug 
(seen in Figure 10) in a large channel, the plug may be removed when the dosimeter is 
optically CT-scanned, and the center of the dosimeter won’t be as dark since the plug has 
been irradiated to the high dose instead of the dosimeter. In Huang’s experiment, a higher 
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dose was given to the large channel dosimeters than to the small channel dosimeters so 
that the dose at large radii would be readable in the scanner. Likewise, a smaller dose was 
given to the small channel dosimeters so that the dose in the center of the dosimeter could 
be read by the scanner. This way, the dose throughout the dosimeter could be measured. 
However, Huang also found that a higher dose than she used could be given to the 
dosimeters, and it was decided that for this experiment, the same, higher dose would be 
given to both channel sizes and both PRESAGE formulations. 
 
 
Figure 8. PRESAGE with 1.5 cm diameter large channel (soft batch). 
 
Figure 9. PRESAGE with 5.3 mm small channel (hard batch). 
 
Figure 10. Irradiated plug for large channel dosimeters; note the darkened end where 
the x-ray tube was located within the Xoft catheter within the plug. 
For this experiment, the larger channel size was 1.5 cm in diameter, with a 
PRESAGE plug, or insert, that fit exactly into the channel to keep the Xoft source secure in 
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a homogenous attenuating medium. The plug was removed for imaging, and the channel 
was filled with matching fluid. The smaller channel size was 5.1 mm in diameter, sized so 
that the Xoft source fit perfectly in place. From Huang's thesis, the smaller channel size was 
used to measure doses out to a radius of 2.5 or 3 cm, and the larger channel size was used 
to measure doses out to the edge of the dosimeter, at a radius of approximately 5 cm. For 
this experiment, however, it was decided that both channel sizes and both formulations 
could be irradiated to 15 Gy at 1 cm without any OD read-out issues. 
2.2 Treatment setup and delivery 
2.2.1 Dose calibration 
Five cuvettes containing the soft PRESAGE formulation and ten cuvettes containing 
the hard PRESAGE formulation were requested from the manufacturer along with the 1 kg 
dosimeters used for this experiment. Cuvettes, seen in Figure 11, are small plastic vials, 
approximately 1 cm square and approximately 5 cm long, containing PRESAGE. Cuvettes 
are used to determine absolute dose for different PRESAGE batches, since PRESAGE is a 
relative dosimeter.  
 
Figure 11. PRESAGE cuvettes for dose calibration. 
Prior to irradiation, the cuvettes were labeled (S1-S5 and H1-H10) and their 
absorbance at 633 nm was determined in a Genesys 20 spectrophotometer (Thermo 
Scientific, Waltham, MA). This established a background optical density. The cuvettes were 
scanned in two directions to ensure the optical density was approximately the same 
throughout.   
The cuvettes were irradiated with an orthovoltage machine at 125 kVp, which has a 
dose rate of 74.76 cGy/min. The cuvettes should have been irradiated at 75 kVp, the beam 
closest to the 50 kVp Xoft energy characterized and available at this institution. However, 
the cuvettes were inadvertently irradiated with the 125 kVp beam instead. The doses to the 
cuvettes were originally calculated assuming the 75 kVp beam, but when the error was 
realized, the doses were recalculated.  
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For the irradiation setup, the cuvettes were placed on top of approximately 10 cm of 
solid water to prevent backscatter, and within an acrylic sheet with a cutout in the center 
large enough to place four cuvettes side-by-side. Any gap within the acrylic sheet was filled 
with previously irradiated cuvettes for consistent material densities. This setup can be seen 
in Figure 12. The SSD was 50 cm, the field size was 10 cm by 10 cm, the irradiation was to 
the surface, and the dose was calculated to muscle. 
 
Figure 12. Cuvette irradiation setup (7). 
The cuvettes were given half their total dose on one side, then turned over 180° and 
irradiated to the rest of the dose. This was to ensure that the cuvettes were evenly 
irradiated to the total dose, so the dose profile would not have any steep gradients. The 
cuvettes were irradiated to an evenly-spaced range of doses, as seen on the x-axes in 
Figures 13-14, with one held aside so a “zero” dose mark could be obtained. The cuvettes 
were irradiated to different doses so a dose calibration curve could be obtained - OD versus 
dose. 
After irradiation, the cuvettes were scanned in the same spectrophotometer at 633 
nm, again in two directions, and the ODs recorded. A graph of OD versus dose was created 
for both batches of cuvettes, as seen in Figures 13-14. Net OD was calculated by 
subtracting the average of the pre-irradiation scan ODs from the average of the post-
irradiation scan ODs.  
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Figure 13. Hard dosimeters dose response curve with a linear fit and corresponding 
R2 value. 
  
Figure 14. Soft dosimeters dose response curve with a linear fit and corresponding 
R2 value. 
2.2.2 Pre-irradiation 
The dosimeters were stored in black bags in a refrigerator kept at 4° C; PRESAGE 
is light and heat sensitive, and this procedure reduces background exposure of the 
dosimeters. Prior to scanning or irradiation, the dosimeter was removed from the fridge and 
allowed to warm up to room temperature for at least six hours.  
Eight total dosimeters were used in this experiment, four of the hard formulation, 
and four of the soft. Of the four hard dosimeters, one had a large channel, and three had a 
y = 0.0328x + 0.0185
R² = 0.9593
-0.500
0.000
0.500
1.000
1.500
2.000
2.500
3.000
0 10 20 30 40 50
O
D
/c
m
Dose (Gy)
Hard Dosimeters Dose 
Response
y = 0.0072x + 0.0221
R² = 0.9701
-0.100
0.000
0.100
0.200
0.300
0.400
0.500
0.600
0.700
0 10 20 30 40 50 60
O
D
/c
m
Dose (Gy)
Soft dosimeters  Dose Response 
21 
 
small channel. Of the four soft dosimeters, two had a large channel, and two had a small 
channel. The dosimeters all had a small base glued on the bottom so they could be 
reproducibly placed and scanned in the DMOS. Since there were two different formulations, 
two different refractive index (RI) matching fluid compositions had to be created prior to the 
pre-irradiation scans. The soft dosimeters were scanned first; mineral oil was used to lower 
the RI to approximately 1.485. Next, the hard dosimeters were scanned; cinnimate was 
added to the tank to raise the RI to approximately 1.495. 
Since UT MD Anderson does not have a Xoft source, after the dosimeters were pre-
irradiation scanned to obtain a measurement baseline, they were shipped in a light-tight box 
to the UWADCL. 
2.2.3 Treatment delivery 
The Xoft Axxent controller is used to deliver treatment in the clinic. However, for this 
experiment, a Modulation Test Fixture (MTF), seen in Figure 15, provided by the 
manufacturer to the UWADCL was used. It mimics the electronic controller and TPS; it 
allows the user to adjust the tube voltage and current, among other settings. The MTF uses 
a Monte Carlo software package to create "treatment plans," which allow time for the 
source voltage and current to ramp up and ramp down. Well chamber measurements can 
be made in either the provided Standard Imaging shielded well chamber (identical to the 
one provided with the commercial unit) or the NIST-calibrated Standard Imaging well 
chamber; for this experiment, measurements were taken in the NIST-calibrated well 
chamber. 
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Figure 15. MTF at UWADCL. 
Due to the complicated procedures required to run the MTF, the staff at UWADCL 
ran the unit according to the irradiation time calculation provided to them. The irradiation 
time calculations had the units minutes per unit air kerma (in U), so that when the well 
chamber measurement of the Xoft source was taken, irradiation time was solved for and 
then plugged into the Monte Carlo system. The manufacturer gave the air kerma strength of 
the selected source, provided by Xoft (Xoft, San Jose, CA), as 126095 U. The UWADCL 
calibrated air kerma strength for this source was 1.180x1012 U/A. 
Initially, the calculated treatment time was less than one minute, which would 
introduce large ramp up errors into the dose calculations. To lengthen the treatment time, 
the weaker of the two provided Xoft Axxent sources was selected for use (SK stated 
previously); unfortunately, this only added a few seconds to the total irradiation time. To 
further lengthen the treatment time, the treatment amperage was lowered; test protocols 
were run at both 200 µA and 100 µA. At 100 µA, the treatment time was three minutes, and 
so the ramp error was greatly reduced. Previous (currently unpublished) studies at UW 
have shown that operating the source at these lower currents is an acceptable method to 
lengthen treatment times to minimize ramping errors.  
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A protocol was created to run at 50 kV and 100 µA for 180 seconds. This procedure 
was followed for all 8 irradiations. However, during all of the soft batch PRESAGE 
irradiations, the source arced part of the way into the irradiation. A new protocol was 
created for each of these cases to irradiate for the remainder of the 180 seconds. This 
introduced more ramp up error into the irradiation, but it did not change the total dose 
delivered by more than 2.7%.  
For the irradiations, the dosimeters were placed in a cylindrical phantom, 
approximately 29 cm in diameter. Foam was used to reduce the diameter to approximately 
21 cm, then the dosimeter was placed on a base that raised it approximately 5 cm above 
the bottom of the phantom. Rice was then poured around the dosimeter, which was still 
enclosed in a black bag to protect it from light. The rice, a tissue equivalent material, was 
used to produce backscatter that would be comparable to the backscatter of the ion 
chamber measurements and the Monte Carlo calculations. Rice was used instead of water 
because PRESAGE, particularly soft batch PRESAGE, is partially soluble in water. The 
dosimeter was centered in the phantom so that it was surrounded on all sides by 
approximately 5 cm of rice. For ease of transfer between dosimeters, a plastic bag was 
placed into the tank for the rice to be poured into and out of. This setup is shown in Figure 
16. 
 
Figure 16. Dosimeter shielded from light and surrounded by rice in phantom. 
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With the room lights out, the Xoft catheter was placed, either directly into the small 
channel or into the PRESAGE plug then into the large channel (seen in Figure 17). In either 
case, the catheter and plug were inserted to the very bottom of the channel. As stated 
previously, all dosimeters were irradiated to 15 Gy at 1 cm with a treatment time of 180 
seconds. In the cases when the source arced, the 180 second treatment time was 
completed, but the dose was calculated to be closer to 15.41 Gy, due to the additional ramp 
up error. The dosimeters were shipped back to IROC-Houston post-irradiation, and 
scanned in the DMOS as soon as the experimenter returned.  
 
 
Figure 17. Xoft Axxent source inside plug inside PRESAGE dosimeter. 
2.3 Imaging and analysis 
2.3.1 Optical-CT imaging 
The dosimeters were scanned post-irradiation according to the methods outlined in 
Chapter 1. Due to the two different PRESAGE batch formulations, the RI of the matching 
fluid was monitored and adjusted as needed to match the RIs used during the pre-
irradiation scans. Reconstruction of the images was also performed according to the 
methods described in Chapter 1. 
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2.3.2 Data Acquisition in MATLAB 
In an earlier work, to extract the TG-43U1 data from the DMOS optical-CT scans, 
the scans were imported into the Computational Environment for Radiotherapy Research 
(CERR) and the OD was scaled according to the calibration curve obtained from the 
cuvettes. Line profiles were taken, which create a plot of dose versus dosimeter radius, and 
parameters were input into an Excel spreadsheet for analysis. Since this is a lengthy 
process, only 12 points from each radius were taken and averaged together (7). To make 
data extraction faster and simpler, as well as to obtain more points for use in the average 
dose, code was written to do this instead.  
Two separate scripts were written - one to calculate the radial dose function, called 
radialunicorns.m, and the other to calculate the anisotropy function, called 
anisotropyunicorns.m. The codes work in similar ways: they both take an average of the 
value of the data cube within an annulus. The coordinate system used to define the annulus 
in PRESAGE is depicted in Figure 18. The annulus is defined as 3 z-planes thick, centered 
around the anode’s z-plane, with the inner and outer radii ±0.5 mm from the defined radius 
given by Rivard et al. (1); an example annulus is shown in Figure 19. For the anisotropy 
function, averages were also taken every 10° for each given radius. The polar angles noted 
were also taken from Rivard et al. (1), for ease of comparison. The entire cube is searched 
for points within the annulus. 
26 
 
 
Figure 18. Diagram of the transverse plane (red dashed circle) and another 
measurement plane at θ (black dashed circle), in the PRESAGE dosimeter. 
The average value of the data cube is output as an unnormalized average dose rate 
at that radius, or at that radius and angle. 
 These two codes are written out in Appendix B. To use them, the user must type the 
location of the input data cube file in the *.m file so it can be loaded, then run the script. 
This data cube is saved from the Reconstruction GUI discussed previously. The script will 
ask the user for the (x,y,z) center of the data cube, i.e., the location of the Xoft Axxent 
anode, from which point the script will do radius and angle calculations. The z-axis is 
defined in the data cube by the DMOS Reconstruction software, and MATLAB uses this 
definition when it imports the data cube. The x- and y-axes are less important because the 
radius and polar angle calculations are both performed with respect to the z-axis only. The 
user will also be asked to enter the size of the data cube (x,y,z). Both of these coordinate 
sets can be obtained by running GUIPhoenixFire.m, a code developed by a fellow lab group 
member, Slade Klawikowski, to extract dose from CyberKnife PRESAGE irradiations. A 
screenshot of the GUIPhoenixFire.m program is shown in Figure 20. 
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Figure 19. The image on the left is a top view of the dosimeter showing the annulus 
described; the z-axis points into the page. The dashed red line is the radius from 
which the delta is applied. The black circle at the center is the channel, and the black 
outline is the outer edge of the dosimeter.   
Notice the sliders at the bottom of the GUI; the long slider allows the user to page 
through the optical-CT slices in z, and the x and y sliders that allow the user to select the 
center of the dosimeter. From these three sliders, the user can determine both the (x,y,z) 
center and the (x,y,z) extent of the data cube. The center of the dosimeter is not its 
measured center, but rather the point in the channel where the anode of the Xoft catheter is 
expected to be. When stepping through the z slices of the dosimeter in the PhoenixFire 
GUI, the anode was assumed to be in the last slice of the channel, as shown in Figure 20. 
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Figure 20. Screenshot of PhoenixFire GUI, showing z slice where anode is located. 
The radialunicorns.m code output a MS Excel spreadsheet of the average relative 
dose rate within each annulus for each radius. The anisotropyunicorns.m code output a MS 
Excel spreadsheet also which contains the average relative dose rate for each radius and 
angle pair. The code allows the user to name select where to save the Excel files. The data 
within these files is used to calculate the TG-43U1 parameters, which are then compared to 
the TG-43U1 parameters given in Rivard et al. (1) for Specific Aim 3.  
2.3.2.1 Testing the code 
To ensure the scripts written worked correctly, a number of test scenarios were 
created where the outcome of the script could be estimated easily by the user. The first test 
was sending a data cube matrix of all ones through the script. The output of the script 
calculated the average value for each radius annulus as one, as expected. Next, a small 
(9x9x9) data cube matrix was created where the value of the data cube was equal to the 
radius at that point, e.g., at r=3, the value is 3. This test matrix returned expected results, 
i.e., the average value at r=3 was ~3. As a final test, a data cube of similar size to those 
used in this project was run through the complete code. The data cube was taken from a 
CyberKnife irradiation, and had two peaks, one sharp and towards the top of the dosimeter, 
and one broad and flat, towards the bottom. The dose from these irradiations had some 
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angular dependence. The code was run twice, using both peaks as the center calculation 
point. The output results were as expected. 
2.4 TG-43U1 Formalism 
The AAPM TG-43U1 report is recommended for dosimetry analysis of a 
brachytherapy source. Until the AAPM Task Group No. 182 Report Recommendations on 
Electronic Brachytherapy Quality Management is released, TG-43U1 will be used.  
Figure 21 shows the polar coordinate system as defined in the report and used 
here. The orientation of the Xoft source in this image is down the z-axis; the L bracket 
denotes the anode location. The report defines the point of interest as P(r,θ), and the 
reference point as P(r0,θ0), where r0 is 1 cm and θ0 is 90° or π/2 radians. These coordinates 
and points are used to determine the radial dose function and the anisotropy function. 
 
Figure 21. Modified TG-43U1 coordinate system for brachytherapy dose calculations. 
L is the active length of the source in centimeters, r is the distance from the center of 
the source to the point of interest P(r,θ) in centimeters, and θ is the polar angle 
between the radius r and the longitudinal (z) axis of the source. (17) 
2.4.1 Air kerma strength.  
Air kerma strength SK is given in units of U, where 1 U = 1 cGy cm2/h = 1 µGy m2/h. 
TG-43U1 defines SK as the air kerma rate in a vacuum due to photons of energy greater 
than δ, at a distance d, multiplied by the distance squared.  
 𝑆𝐾 =  𝐾?̇?(𝑑)𝑑
2 Eqn. 4 
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The distance d is defined as the distance from the source center to the point of 
interest where SK is specified. The energy cutoff δ is usually set to 5 keV to exclude low 
energy photons in the XOFT source emission spectrum that do not deliver significant dose 
past 0.1 cm in tissue. The air kerma rate is generally measured with a free air device at 
large (~1m) distances.  
Air kerma strength values are reported by the manufacturer, but can also be 
calibrated by an ADCL, which is traceable to the 1999 NIST standard for I-125 model 
MED3631-A/M (17). However, for the Xoft source, there is no NIST standard for air kerma 
strength, so the workaround calibration procedure is used. 
2.4.2 Air kerma rate calibration  
Because there is no NIST standard for this source, a workaround has been created 
by the UWADCL by combining the procedures in TG-43U1, the task group on 
brachytherapy dosimetry, and TG-61, which covers low energy (40-300 kV) x-ray beam 
dosimetry.  
First, the air kerma of an I-125 seed is measured in the shielded well chamber which 
comes with the Xoft system, using the insert that places the seed at the “sweet spot.” The 
sweet spot is defined as the point in the well chamber at which the reading from the source 
is at a maximum.(14) The calibration coefficient "C" is calculated as the air kerma divided 
by the corrected chamber current. Next, the Xoft source is placed in an Attix free air 
chamber (FAC) and the output is measured. The ratio "R" is taken of the Xoft and I-125 
coefficients, so that NSK = R x C, and NSK is defined as the Xoft air kerma in the well 
chamber. This NSK value is placed in the TPS as the nominal air kerma, and is compared to 
each new source's measured air kerma in the well chamber.  
 In clinical use, the air kerma strength of the source is measured prior to each 
fraction in the attached shielded Standard Imaging well chamber, using the insert described 
previously. This air kerma strength measurement, in U, is input into the TPS, which 
calculates dwell time and position.  
 The attached well chamber is calibrated every two years by the ADCL, as per 
requirements. The Xoft manual speaks of compensated air kerma, which is defined as air 
kerma that is temperature and pressure corrected. The final equation for compensated air 
kerma is, in units of U:  
 𝑆𝐾 =  𝑁𝑆𝐾 ×  𝑃𝑒𝑙𝑒𝑐  × 𝑀𝑟𝑎𝑤  ×  𝐶𝑇,𝑃  × 𝑃𝑎𝑙𝑡𝑖𝑡𝑢𝑑𝑒 Eqn. 5 
2.4.3 Dose rate 
The 2D dose rate to water equation as specified in TG-43U1 is  
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?̇?(𝑟, 𝜃) = 𝑆𝐾  ×  Λ × 
𝐺𝐿(𝑟, 𝜃)
𝐺𝐿(𝑟0, 𝜃0)
 × 𝑔𝐿(𝑟) × 𝐹(𝑟, 𝜃) Eqn. 6 
However, for this experiment, Gp(r,θ) and gp(r) are used, as was done in the Rivard et al. 
paper (1). This formalism assumes that the source has a cylindrically symmetric dose 
distribution with respect to the z-axis, and that the radiation emanates from a point source. 
Dose rate is in units of cGy per hour. The dose rate in PRESAGE was calculated using this 
equation and the tables in the Xoft manual (24). These tables are located in Appendix A. All 
dosimeters were irradiated to the same dose, so all dosimeters have the same calculated 
dose rate. The calculated dose rate for the PRESAGE irradiations was 
 ?̇?(1 𝑐𝑚, 90°) = 126095 𝑈 ×  0.709 𝑐𝐺𝑦 ℎ−1𝑈−1  × 1 × 1 × 1 = 894 𝐺𝑦 ℎ−1 Eqn.7 
2.4.4 Dose rate constant 
TG-43U1 defines the dose rate constant in water (Λ) as the ratio of the dose rate at 
the reference point to the air kerma strength.  
 Λ =  
?̇?(𝑟0, 𝜃0)
𝑆𝐾
 Eqn. 8 
Λ has units of cGy per hour per U. The dose rate constant for Xoft was measured in both 
solid and liquid water, as well as calculated using a Monte Carlo model. The unfiltered 
source dose rate constant was not published in Rivard et al. (1), and so is taken from the 
Xoft Operator’s Manual. 
 
 Dose Rate Constant (cGy hr-1 U-1) 
Unfiltered 50 kV source 0.709 
Table 3. Dose rate constant (24) 
  
2.4.5 Geometry function 
According to TG-43U1, the geometry function provides an inverse square law 
correction based on the approximate spatial distribution of radioactivity in the source. 
Therefore, there is both a point source and a line source approximation. The effective 
length Leff of the anode in the Xoft source is 0.1 cm. Rivard et al. (1) states that at this small 
Leff, the difference between using the line source approximation and the point source 
approximation is not more than 1%, therefore they set Leff = 0, and use the point source 
approximation for the geometry function. As this paper is comparing its results to that 
paper, the same steps will be taken here. Therefore, the geometry function Gp(r,θ) is 1/r2 or 
(r0/r)2, where r and r0 are defined as before.  
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Radius (cm) 1 2 3 4 5 
Gp(r) 1 4 9 16 25 
Table 4. Geometry factors for a point source. 
2.4.6 Anisotropy function 
TG-43U1 defines the 2D anisotropy function F(r,θ) as the variation in dose as a 
function of polar angle relative to the transverse plane (i.e., at θ=90°). The equation is  
 𝐹(𝑟, 𝜃) =  
?̇?(𝑟, 𝜃) 𝐺𝐿(𝑟, 𝜃0)
?̇?(𝑟, 𝜃0) 𝐺𝐿(𝑟, 𝜃)
 Eqn. 9 
F(r0,θ0) = 1, and will decrease as r decreases, as θ approaches 0° or 180°, as 
encapsulation thickness increases, or as photon energy decreases. For this experiment, to 
match the Rivard et al. data (1), the point source geometry function Gp(r,θ) was used. The 
values for the anisotropy function for Xoft are shown in the table below, taken from the 
Rivard et al. paper. (1, 24)  
 
θ(degrees) F(2,θ) F(3,θ) F(5,θ) 
0 0.993 1.018 1.050 
10 1.001 1.027 1.054 
20 1.013 1.037 1.059 
30 1.024 1.042 1.065 
40 1.052 1.065 1.075 
50 1.072 1.080 1.080 
60 1.075 1.079 1.075 
70 1.063 1.065 1.062 
80 1.037 1.038 1.036 
90 1.000 1.000 1.000 
100 0.953 0.954 0.950 
110 0.895 0.896 0.894 
120 0.820 0.824 0.825 
130 0.709 0.721 0.731 
140 0.564 0.590 0.616 
150 
 
0.426 0.473 
160 
  
0.364 
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Table 5. Measured anisotropy function at 50 kV (1) 
 The anisotropy function in PRESAGE was calculated using the above equation, 
which reduces to 
 𝐹(𝑟, 𝜃) =  
?̇?(𝑟, 𝜃)
?̇?(𝑟, 90°) 
 Eqn. 10 
The dose rate values were pulled from the data using the script, as described in the Data 
Acquisition section. The dose rate values were corrected for zero dose as described in 
Chapter 3.  
2.4.7 Radial Dose Function 
The radial dose function gp(r) accounts for dose falloff due to attenuation and 
scattering; this does not include dose falloff from the inverse square law, since that is 
already accounted for in the geometry function. The equation for a point source (1D) is  
 𝑔𝑝(𝑟) =  
?̇?(𝑟, 𝜃0) 𝐺𝑝(𝑟0, 𝜃0)
?̇?(𝑟0, 𝜃0) 𝐺𝑝(𝑟, 𝜃0)
 Eqn. 11 
Below are the values from Rivard et al. (1). 
 
r (cm) gp(r ) 
1.0 1.000 
1.2 0.920 
1.4 0.848 
1.6 0.786 
1.8 0.732 
2.0 0.683 
3.0 0.511 
4.0 0.399 
5.0 0.317 
Table 6. Radial dose function values measured at 50 kV (1) 
The radial dose function in PRESAGE is calculated using the equation above, which 
reduces to 
 𝑔𝑝(𝑟) =  
?̇?(𝑟, 90°) × 𝑟2 
?̇?(1,90°)
 Eqn. 12 
The dose rate values were pulled from the data using the script, as described in the Data 
Acquisition section. The dose rate values were corrected for zero dose as described in 
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Chapter 3. Note that for the radial dose function, the measurements are taken at different 
radii, but all in the transverse (θ = 90°) plane. 
3 Results for Xoft Source 
3.1 Soft Dosimeter Batch 
The soft PRESAGETM dosimeters were excluded from the results. The formulation 
was created so it would fade over time after irradiation, and it was observed that in the short 
time between irradiation with Xoft at the UWADCL and the post-irradiation scan at IROC-
Houston, the signal in the soft dosimeters faded too much to provide useful dose 
information. Figure 22 shows the pre-irradiation and post-irradiation images for comparison. 
It is also noted here that the Xoft source formed an electric arc during each irradiation of a 
soft dosimeter, but not during any of the hard dosimeter irradiations. This was thought to be 
a random effect, the only result of which was the soft dosimeter irradiations were then 
forced to be delivered in a fractionated manner, e.g., one 120 second irradiation followed by 
a 60 second irradiation, instead of one 180 second irradiation.  
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Figure 22. Prescan and postscan images of a soft dosimeter with a large channel. 
Note that the irradiation seems to have had almost no effect on the dosimeter, 
probably due to fading. 
3.2 Radial dose function 
 The radial dose function measured and calculated in PRESAGE is shown in Table 
7. This data is taken from a single small channel dosimeter; the average radial dose 
function data from all four dosimeters is shown in Appendix C. PRESAGE measurements at 
4 cm radius were removed from the analysis due to the negligible level of signal above the 
background that existed there; no data was expected at r = 5 cm due to the size of the 
dosimeters and edge effects. The PRESAGE-measured radial dose functions for r = 1 cm 
to r = 2 cm agree with those calculated by and Rivard et al. (1) to within 6%. However, at r = 
3 cm, the radial dose function measured in PRESAGE shows an under-response by 51.1%; 
this suggests that the noise level at r = 3 cm is comparable to the measureable dose at that 
radius, probably due to the age of the dosimeter during its final scan and the exacerbation 
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of edge effects in PRESAGE as the dosimeter ages. A graphical representation of the radial 
dose function comparison is shown in Figure 23. 
 
r (cm) 
Rivard 
et al. 
value 
PRESAGE 
value 
Percent 
Error  
1 1 1 0 
1.2 0.920 0.958 4.2 
1.4 0.848 0.894 5.5 
1.6 0.786 0.831 5.7 
1.8 0.732 0.751 2.6 
2 0.683 0.689 0.9 
3 0.511 0.250 51.1 
Table 7. Radial Dose Function Comparison 
 
 
Figure 23. Graphical comparison of the radial dose function. Rivard et al. is in blue 
diamonds, and PRESAGE is in red squares. 
3.3 Anisotropy function  
 Table 8 shows the anisotropy function measured and calculated in PRESAGE. 
Refer to Table 5 for the Rivard et al. anisotropy function values. The data from PRESAGE 
at r = 5 cm was not included because no data is expected at that radius, due to the size of 
the dosimeter and edge effects of PRESAGE. The angles 140° and 160° are very close to 
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the channel, subjecting the readings there to edge effects. Table 9 shows the percent error 
values for the anisotropy function, comparing the Rivard et al. (1) values to the PRESAGE 
values. 
 
θ°/r(cm) 2 3 
0 1.260 1.371 
10 1.202 1.239 
20 1.193 1.315 
30 1.280 1.264 
40 1.307 1.266 
50 1.285 1.299 
60 1.346 1.261 
70 1.316 1.224 
80 1.196 1.137 
90 1.000 1.000 
100 0.864 0.930 
110 0.693 0.835 
120 0.641 0.708 
130 0.832 0.631 
140 1.316 0.542 
150 1.029 2.154 
160 1.231 4.970 
Table 8. Anisotropy function measured in PRESAGE 
 
 Ignoring the extreme outlier for each radius (θ=140° for r=2, and θ=150° for r=3), the 
r = 2 cm values are within 27% of the Rivard et al. data, and the r = 3 cm values are within 
35% of the Rivard et al. data.  
 
θ°/r(cm) 2 3 
0 26.9 34.6 
10 20.1 20.6 
20 17.8 26.8 
30 25.0 21.3 
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40 24.3 18.9 
50 19.9 20.3 
60 25.2 16.8 
70 23.8 14.9 
80 15.4 9.5 
90 0.0 0.0 
100 9.3 2.5 
110 22.6 6.8 
120 21.9 14.1 
130 17.3 12.5 
140 133.3 8.2 
150 
 
405.6 
160 
  
Table 9. Anisotropy function: Percent Error 
 
 Table 10 shows the standard deviation and Table 11 shows the coefficient of 
variance expressed as a percent for the PRESAGE anisotropy function data. These values 
are lower closer to θ = 90°, and increase as θ moves away from the transverse plane. This 
suggests that the measurements taken closest to the source are the most accurate; 
measurements in PRESAGE of the dose distribution from the Xoft appear to have a more 
rapid falloff than expected at large radii and at polar angles further from the transverse 
plane.  
 
θ°/r(cm) 2 3 
0 0.589 0.375 
10 0.557 0.349 
20 0.516 0.342 
30 0.514 0.322 
40 0.445 0.271 
50 0.360 0.223 
60 0.358 0.127 
70 0.345 0.060 
80 0.162 0.038 
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90 0.000 0.000 
100 0.090 0.046 
110 0.153 0.115 
120 0.127 0.079 
130 0.339 0.166 
140 1.361 0.238 
150 1.043 2.025 
160 1.112 7.074 
Table 10. PRESAGE Anisotropy function: Standard Deviation 
θ°/r(cm) 2 3 
0 46.8 27.4 
10 46.3 28.1 
20 43.2 26.0 
30 40.2 25.5 
40 34.0 21.4 
50 28.0 17.2 
60 26.6 10.1 
70 26.2 4.9 
80 13.5 3.3 
90 0.0 0.0 
100 10.4 4.9 
110 22.1 13.8 
120 19.9 11.2 
130 40.7 26.3 
140 103.4 43.9 
150 101.3 94.0 
160 90.4 142.3 
Table 11. PRESAGE Anisotropy Function: Percent Coefficient of Variance 
 Figures 24 and 25 plot the anisotropy function at both radii and compare the Rivard 
et al. values with the PRESAGE values. 
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Figure 24. Anisotropy function for r=2cm. 
 
 
Figure 25. Anisotropy function for r=3cm. 
 
4 Discussion  
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 During the initial data analysis process, concentric rings were seen in the final data 
images; an example of this artifact is shown in Figure 26. These artifacts varied in 
thickness, brightness, and location, but were centered in the dosimeter and not around the 
channel, as might have been expected. These artifacts made the data past a radius of ~3 
cm in the dosimeters unusable. An investigation was undertaken to determine the artifacts’ 
cause and possible solutions. 
  
 
Figure 26. Reconstructed image showing the concentric ring artifact which is 
centered in the dosimeter and not around the dosimeter’s channel. 
The floods and dark images were checked to determine if there were any streaks 
that could be causing the rings. Different center of rotation (COR) columns were used in the 
image reconstructions as an inappropriate COR can cause the appearance of rings. A stray 
light correction was performed. Different floods were taken and used to reconstruct the 
images again.  Pre-irradiation and post-irradiation scans were reconstructed separately and 
inspected. The rings appeared in both sets of images, though the appearance of the rings 
differed in each image; an example of these results is shown in Figure 27. The post-
irradiation scan was repeated and reconstructed for each dosimeter, but the rings 
remained. Two unirradiated dosimeters were scanned, one from each batch, then 
reconstructed as pre-irradiation scans only. The artifacts were visible in those images as 
well. No other lab group members had seen these concentric rings in any current or 
previous data, and no one had used the same PRESAGETM batches as were used here. A 
literature search was done, but the only concentric ring artifacts found were in gel 
dosimeters, and the causes of which did not apply to PRESAGE dosimetry (47, 48).  
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Figure 27. Top row shows pre-irradiation scans of two different dosimeters. Bottom 
row shows post-irradiation scans of two other dosimeters. Note the differing 
appearance of the rings in each image. 
 Finally, a query was sent to Titania Juang at Duke University. By looking at the 
number of counts per pixel in the RAW images, she determined that the flood and the 
projection images had been taken at different shutter values. The projection images were 
taken at a much higher shutter value than the flood, so that when the flood was used to 
correct the projection images during reconstruction, negative counts resulted in the final 
image. The flood image was darker than the dosimeter in the projection image, and had 
counts that were ~1000 lower than the projection images’ counts; this can be seen in Figure 
28. 
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Figure 28. Projection image on left with Index (counts) of 4095. Flood image on right 
with Index at same location as in projection image of 644.9, giving a delta of over 
3000. 
This count difference was confirmed. Since the issue was with the projection 
images, which could not be retaken due to time constraints, the RAW projection images 
were pulled into MATLAB. MATLAB’s image processing tools were explored as a possible 
solution. A post-irradiation projection image was darkened using the ‘brighten(-0.5)’ 
command. The new image, seen in Figure 29, showed that there was no data outside a 
radius of approximately 3 cm because the dosimeter there had been washed out by so 
much light due to the high shutter value. The same was done to a pre-irradiation projection 
image with the same result. In these darkened images, the cause of the concentric rings 
could be seen. It is theorized that the cause of the rings is the non-homogeneous light field 
of the IROC-Houston DMOS. It was already known that the field was darker in the center 
and brighter at the edges, but now images of how the light field brightness changes with 
radius show this inhomogeneity in more detail. This phenomenon had not been seen until 
now because other lab members used the correct shutter setting and did not use such large 
dosimeters as were used here. Since image processing could not improve the amount of 
data available in the images, another solution was attempted. 
 
44 
 
 
Figure 29. The extent of the available data (300-900 on the x-scale) can be seen in 
this darkened image of a post-irradiation scan projection image. Also seen are the 
causes of the concentric rings in the reconstruction images (bands of different 
contrast at 200, 300, 800, and 900 on the x-scale). 
4.2 Solution to Remove the Artifact 
The post-irradiation scans for the hard dosimeters were retaken with the correct shutter 
setting; an example projection image is shown in Figure 30, and compared to a flood image 
taken at the same shutter value. In Figure 31 is an image showing the absence of artifacts 
in the retaken image. The shutter setting was not discussed in the RPC DMOS Scanning 
Guide (39) and had been left out of lab member training. This issue has now been 
remedied. The scans were reconstructed as post-irradiation scans only, since the pre-
irradiation scans could not be retaken. The data analysis was performed using these 
reconstructed post-irradiation scans. However, since these post-irradiation scans were 
performed 2 months after the irradiation, the dosimeters have aged. Older dosimeters are 
darker overall, and the radiation signal faded. Furthermore, edge effects are exacerbated in 
older dosimeters. The data obtained from the new post-irradiation scans will be subject to 
these age effects, and will not compare well with the Rivard et al. (1) data. 
However, since the “post scan” only reconstruction was performed, no subtraction of 
background OD value in the dosimeter was completed. To remedy this, the dose rates at 
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large radii for each dosimeter were plotted and a background value was chosen at the point 
where the data appeared to level out in the plot. This background value was then 
subtracted from all dose rates. An example of this plot is shown in Figure 32. 
 
 
Figure 300. Projection image on left with Index 3692. Flood image on right with Index 
at same location as in projection image of 3964, giving a delta of less than 30. 
 
 
Figure 311. Final post-irradiation scan of a dosimeter showing no ring artifact. The 
rings seen in this image relate to the dose at various radii. 
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Figure 322. Example background level plot. The background value selected for this 
dosimeter was 0.0150. 
4.2.1 Dose Rate and Dose Rate Constant 
Due to this background subtraction correction and the unavailability of applicable 
cuvette dose calibration curves, the doses reported are relative to each dosimeter. 
Therefore, the dose rate and dose rate constants were not calculated for comparison. 
5 Uncertainty Analysis 
 TG-43U1 (17) recommends a generic uncertainty analysis for dosimetric quantities 
measured and calculated for brachytherapy sources. TG-138 (49) outlines a procedure for 
this analysis. Table 12 contains a summary of Type A (k=1) and Type B (k=1) uncertainties 
as well as an estimation of the expanded relative uncertainty (k=2), which is defined as a 
95% confidence limit. The total standard uncertainty (k=1) for the dose rates measured in 
PRESAGE was estimated to be 5.7%, and the expanded uncertainty (k=2) was 11.4%. 
 The Type A, or statistical, uncertainties in this experiment were all related to the 
measurements taken in PRESAGE, for both the radial dose function and the anisotropy 
function. These uncertainties were calculated as the uncertainty in the dose rate at a 
selected radius (or radius and polar angle) and the uncertainty in the dose rate at the 
reference point, added in quadrature. The uncertainties in the dose rates were calculated 
as a percent coefficient of variance. An example for a selected radius and polar angle will 
be presented in the sections that follow. There were several Type B, or random, 
uncertainties in this experiment. First, the uncertainty of the air kerma strength measured at 
the UWADCL includes the equipment used to make the measurement and the 
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reproducibility of the measurement; this was estimated to be 5% (k=1). The uncertainty in 
the current and voltage supplies used to run the Xoft source was estimated to be less than 
1%. Since the anode in the Xoft source is not a point source but has a finite and 
measureable thickness, this introduces 1.5% uncertainty into the experiment. PRESAGETM 
is not exactly water-equivalent, as discussed previously, and so this introduces an 
estimated 2% uncertainty into the experiment.  
 The total standard uncertainty is the quadrature sum of all the listed uncertainty 
components, and the expanded relative uncertainty is simply twice that value. 
 
Uncertainty Component Type A (k=1) Type B (k=1) 
Xoft air kerma strength (UWADCL)  5.0% 
Current, voltage uncertainty   <1.0% 
Anode thickness  1.5% 
Water-equivalency of PRESAGE  2.0% 
Total standard uncertainty (k=1) 5.7% 
Expanded relative uncertainty (k=2) 11.4% 
Table 12. Uncertainty in PRESAGE measurement of Dose Rate 
5.1 Anisotropy function  
 The anisotropy function is a ratio between two dose rates. Therefore, uncertainty in 
the Xoft air kerma strength measurement will cancel out. The uncertainty in current will 
cancel out as well, leaving the voltage uncertainty as <1%, which will be ignored. The Type 
A uncertainty at a radius of 3 cm and a polar angle of 60° is 64.4%. This large uncertainty in 
the measurement dominates the uncertainty estimate for the anisotropy function. Thus, the 
total uncertainty (k=1) for the anisotropy function is 64.4%, and the expanded uncertainty 
(k=2) is 128.9%. 
5.2 Radial dose function 
 The radial dose function is also a ratio of two dose rates, so the Xoft air kerma 
strength measurement and tube current uncertainties cancel out here as well, and the 
uncertainty in the voltage can be ignored as before. The Type A uncertainty at a radius of 2 
cm is 29.5%. Therefore, the total uncertainty (k=1) is 29.6% and the expanded uncertainty 
(k=2) is 59.2%. 
6 Conclusion 
The hypothesis for this project was rejected. The PRESAGETM dosimeters were not 
able to measure, with 95% confidence, the AAPM TG-43U1 dosimetric parameters of the 
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Xoft Axxent electronic brachytherapy source, to within ±5%/3mm of Rivard’s published 
values. 
Despite errors in methodology, the radial dose and anisotropy functions were more 
accurate closer to the source. The radial dose function from r=1 cm to r=2 cm was within 
6% of expected values. The anisotropy function for θ=90°±10° was within 16% of the 
accepted values for r=2 cm and within 10% for r=3 cm. The experiment should be repeated. 
To improve this experiment, a new batch of hard dosimeters, containing three of 
each channel size, should be irradiated using the Xoft source. The pre-irradiation scans, 
post-irradiation scans, and flood images should all be taken at the same and correct shutter 
value. Prior to shipping the dosimeters to the UWADCL for irradiations, the pre-irradiation 
scans should be reconstructed and viewed to ensure the images are “clean” and will 
provide acceptable data. A dose calibration should be performed by irradiating 10 cuvettes 
from the same batch as the dosimeters on the 75 kVp orthovoltage machine; the doses 
delivered should range from 0 Gy to 18 Gy. When irradiating the small channel dosimeters, 
a dose larger than 15 Gy may be given to ensure the OD at r = 5 cm is detectable. 
As for future work, it would be greatly useful to the lab group, especially future 
members, to have the cuvette irradiation procedures written out for both orthovoltage and 
MV linear accelerator machines. The DMOS Scanning Guide should also be updated with a 
checklist for use during each scan, as well as further explanations on what each scanning 
parameter controls, how it can be adjusted, and when it should be adjusted. A procedure on 
how to adjust the matching fluid, including images for comparison, should be written and 
included in the lab group’s training materials. PRESAGE dose calibration data for each 
batch should be kept in a lab group shared folder for all to reference. The effects of age on 
a dosimeter, in relation to edge effects, should be further investigated. The two scripts 
written for this project could be updated to output the standard deviation for the average 
dose rate calculated for each input dose cube. 
This project’s findings illustrate the pitfalls of PRESAGE dosimetry, and the need for 
accurate and thorough training documents. However, PRESAGE remains a viable method 
to conduct 3D brachytherapy dosimetry, which could greatly improve the understanding of 
dose distributions for new brachytherapy sources as they are developed, as well as 
advance quality assurance methods. Future work in dosimetry including the use of 
brachytherapy applicators in anthropomorphic PRESAGE may begin a new chapter in 3D 
dosimetry. 
Appendix A  
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Xoft Source TG-43 Parameter Tables (24) 
 
Dose Rate Constant 
 Dose Rate Constant (cGy hr-1 U-1) 
Unfiltered 50 kV source 0.709 
 
Radial Dose Function g(r) 
Radius (cm) Dose Function 
0.5 1.418 
1.0 1.000 
1.5 0.780 
2.0 0.641 
3.0 0.470 
4.0 0.362 
5.0 0.286 
6.0 0.229 
7.0 0.185 
8.0 0.150 
9.0 0.122 
10.0 0.0989 
12.0 0.0655 
15.0 0.0352 
 
Anisotropy Function F(r, θ) 
 Angle (degrees) 
Radius 
(cm) 
0 5 10 15 20 25 30 35 40 45 50 55 60 
0.5 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.252 0.425 0.556 0.676 0.743 0.796 
1.0 0.000 0.000 0.000 0.241 0.211 0.211 0.301 0.380 0.483 0.575 0.667 0.738 0.800 
1.5 0.000 0.000 0.248 0.267 0.258 0.274 0.361 0.435 0.530 0.609 0.689 0.750 0.811 
2.0 0.000 0.000 0.272 0.297 0.298 0.322 0.405 0.476 0.564 0.637 0.709 0.765 0.820 
3.0 0.000 0.250 0.296 0.319 0.327 0.357 .0426 0.508 0.590 0.656 0.721 0.773 0.824 
4.0 0.000 0.279 0.321 0.343 0.356 0.389 0.450 0.526 0.603 0.665 0.726 0.775 0.825 
5.0 0.000 0.290 0.329 0.349 0.364 0.419 0.473 0.545 0.616 0.674 0.731 0.778 0.825 
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6.0 0.000 0.313 0.349 0.369 0.385 0.424 0.489 0.562 0.626 0.681 0.737 0.782 0.828 
7.0 0.000 0.334 0.365 0.383 0.406 0.429 0.504 0.579 0.636 0.692 0.743 0.794 0.830 
8.0 0.000 0.349 0.377 0.397 0.420 0.441 0.515 0.589 0.643 0.698 0.747 0.797 0.831 
10.0 0.000 0.371 0.395 0.412 0.439 0.459 0.531 0.604 0.657 0.707 0.753 0.800 0.832 
12.0 0.000 0.384 0.407 0.426 0.454 0.473 0.542 0.613 0.663 0.712 0.757 0.801 0.831 
15.0 0.000 0.401 0.417 0.437 0.465 0.482 0.550 0.622 0.667 0.715 0.758 0.801 0.831 
 
Anisotropy Function F(r, θ) (continued) 
 Angle (degrees) 
Radius 
(cm) 
65 70 75 80 85 90 95 100 105 110 115 120 
0.5 0.840 0.883 0.914 0.945 0.970 1.000 1.021 1.041 1.053 1.063 1.065 1.064 
1.0 0.840 0.884 0.916 0.948 0.973 1.000 1.020 1.040 1.053 1.065 1.069 1.072 
1.5 0.849 0.890 0.920 0.950 0.975 1.000 1.020 1.038 1.052 1.064 1.069 1.074 
2.0 0.858 0.895 0.924 0.953 0.977 1.000 1.019 1.037 1.050 1.063 1.069 1.075 
3.0 0.860 0.896 0.925 0.954 0.977 1.000 1.019 1.038 1.052 1.065 1.072 1.079 
4.0 0.860 0.895 0.924 0.952 0.976 1.000 1.019 1.037 1.050 1.064 1.070 1.077 
5.0 0.860 0.894 0.922 0.950 0.975 1.000 1.018 1.036 1.049 1.062 1.069 1.075 
6.0 0.862 0.896 0.924 0.952 0.976 1.000 1.019 1.037 1.051 1.064 1.071 1.078 
7.0 0.866 0.898 0.929 0.954 0.979 1.000 1.021 1.039 1.056 1.066 1.076 1.081 
8.0 0.865 0.898 0.927 0.953 0.979 1.000 1.022 1.039 1.056 1.066 1.076 1.082 
10.0 0.866 0.898 0.927 0.952 0.978 1.000 1.021 1.039 1.055 1.066 1.078 1.083 
12.0 0.866 0.897 0.926 0.952 0.977 1.000 1.020 1.039 1.056 1.068 1.077 1.089 
15.0 0.865 0.895 0.925 0.951 0.977 1.000 1.022 1.039 1.057 1.071 1.083 1.093 
 
Anisotropy Function F(r, θ) (continued)  
 Angle (degrees) 
Radius 
(cm) 
125 130 135 140 145 150 155 160 165 170 175 180 
0.5 1.057 1.048 1.028 0.997 0.968 0.944 0.907 0.902 0.893 0.890 0.892 0.887 
1.0 1.067 1.062 1.044 1.027 1.005 0.980 0.967 0.960 0.954 0.948 0.947 0.940 
1.5 1.072 1.068 1.055 1.042 1.025 1.006 0.998 0.992 0.986 0.980 0.974 0.969 
2.0 1.074 1.072 1.062 1.052 1.038 1.024 1.019 1.013 1.007 1.001 0.997 0.993 
3.0 1.080 1.080 1.073 1.065 1.054 1.042 1.040 1.037 1.032 1.027 1.023 1.018 
4.0 1.079 1.080 1.075 1.070 1.062 1.054 1.051 1.048 1.044 1.041 1.037 1.034 
5.0 1.078 1.080 1.078 1.075 1.070 1.065 1.062 1.059 1.057 1.054 1.052 1.050 
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6.0 1.081 1.083 1.081 1.080 1.077 1.073 1.071 1.069 1.066 1.064 1.064 1.064 
7.0 1.086 1.086 1.086 1.085 1.083 1.082 1.080 1.078 1.076 1.075 1.073 1.079 
8.0 1.090 1.087 1.088 1.088 1.090 1.084 1.084 1.085 1.080 1.079 1.081 1.080 
10.0 1.091 1.091 1.092 1.094 1.097 1.096 1.092 1.092 1.089 1.087 1.093 1.090 
12.0 1.094 1.094 1.097 1.098 1.105 1.103 1.101 1.101 1.097 1.097 1.102 1.095 
15.0 1.101 1.101 1.105 1.106 1.113 1.111 1.110 1.109 1.107 1.107 1.105 1.110 
 
Appendix B 
Radialunicorns.m Code 
%radialunicorns by sierra 
%purpose of this code is currently to spit out average dose/OD values from 
%input data cubes at various radii from a center point entered by the user 
%for use in TG-43U1 radial dose fcn 
  
clear; 
clc; 
  
%input data cube, either manually, or in prompt  
% [filename,pathname] = uigetfile('*.mat','PROMPT TEXT HERE'); 
% load([pathname,filename]); 
load('S:\SHARED\Radiation physics\Slade\Top Secret Unicorn Data\8-10-
12Bnew data cube.mat'); 
%load('C:\Users\jsirwin\Desktop\IMPORTANT DATA CUBES\ss2 data cube.mat'); 
  
%enter center coordinates 
% cx=0; 
% cy=0; 
% cz=0; 
% cx = input('Enter center x coordinate: '); 
% cy = input('Enter center y coordinate: '); 
% cz = input('Enter center z coordinate: '); 
cx=71; 
cy=72; 
cz=114; 
zsmall=0; 
zbig=0; 
zsmall=cz-1; 
zbig=cz+1; 
  
%enter extent of x, y, z coordinates for use in calculation 
% xmax=0; 
% ymax=0; 
% zmax=0; 
% xmax = input('Enter maximum x coordinate: '); 
% ymax = input('Enter maximum y coordinate: '); 
% zmax = input('Enter maximum z coordinate: '); 
xmax=140; 
ymax=140; 
zmax=151; 
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%set real radii to loop through, along with annulus radii (delta from 
real) 
r=0; 
R=0; 
delta=0; 
radius=[10:2:70]; %radius in mm 
num_radii = length(radius); %so can spit out pixelcount & average as 
arrays 
delta=.5; 
r=radius-delta; 
R=radius+delta; 
  
%code to ensure that "negative" dose is set to zero dose 
Negativeindicies=find(ReconstructedSlices.cube<0); 
ReconstructedSlices.cube(Negativeindicies)=0; 
  
%search for pixels within annulus then adds them up for statistics 
analysis 
%also computes average value at pixel (sum) for OD/DOSE output 
%borrowed from slade's phoenixfire code 
Sum=zeros(1,num_radii); 
Average=zeros(1,num_radii); 
PixelCount=zeros(1,num_radii); 
for i=1:num_radii 
    for z=zsmall:zbig 
        for x=1:xmax 
            for y=1:ymax 
                if (r(i)<(sqrt((cx-x)^2 + (cy-y)^2)) && (sqrt((cx-x)^2 + 
(cy-y)^2)<R(i))) 
                   Sum(i)=Sum(i) + ReconstructedSlices.cube(x,y,z); 
                   PixelCount(i)=PixelCount(i)+1;  
                end 
            end 
        end 
    end 
    Average(i)=Sum(i)/PixelCount(i); 
end 
  
%this section exports my data to an excel file 
%asks where you want to save the excel file, and what to call it 
[fileName, pathName]=uiputfile('*.xlsx','Export Profile'); 
%changes my 3 data arrays into vertical cells & creates one big matrix 
data=num2cell([radius; Average; PixelCount]'); 
%name each column of my data cells 
titles = {'Radius', 'Average Dose', 'Pixel Count'}; 
%place correct title at top of correct data column (cat two things 
together) 
dataout=cat(1,titles,data); 
%writes to the designated file the concatenated matrix i created above 
xlswrite(fullfile(pathName,fileName),dataout); 
 
Anisotropyunicorns.m Code 
%anisotropyunicorns by sierra 
%purpose of this code is currently to spit out average dose/OD values from 
%input data cubes at various radii and angles from a center point entered 
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%by the user for use in TG-43U1 anisotropy fcn 
  
clear; 
clc; 
  
%input data cube;  
%[filename,pathname] = uigetfile('*.mat','Enter data cube file location: 
'); 
% load([pathname,filename]); %to load file from prompt 
%load('C:\Users\jsirwin\Desktop\IMPORTANT DATA CUBES\ss2 data cube.mat'); 
load('S:\SHARED\Radiation physics\Slade\Top Secret Unicorn Data\8-10-
12Bnew data cube.mat'); 
  
%enter center coordinates 
% cx=0; 
% cy=0; 
% cz=0; 
% cx = input('Enter center x coordinate: '); 
% cy = input('Enter center y coordinate: '); 
% cz = input('Enter center z coordinate: '); 
cx=71; 
cy=72; 
cz=114; 
  
%enter extent of x, y, z coordinates for use in calculation 
% xmax=0; 
% ymax=0; 
% zmax=0; 
% xmax = input('Enter maximum x coordinate: '); 
% ymax = input('Enter maximum y coordinate: '); 
% zmax = input('Enter maximum z coordinate: '); 
xmax=140; 
ymax=140; 
zmax=151; 
  
%define all my radius, delta, and angle variables outside for loop 
theta = [0:10:160];  
thetaradians = zeros(size(theta)); 
radius = [10, 20, 30, 40, 50]; %radius in mm; added 10 for checks, 40 just 
b/c 
num_radii = length(radius); %get number of radii checking 
thetaradians = theta*pi()/180; 
num_radian = length(thetaradians); %get number of angles checking 
delta = 0; 
r = 0; 
R = 0; 
zsmall=0; 
zbig=0; 
delta = .5; %in mm 
  
%code to ensure that "negative" dose is set to zero dose 
Negativeindicies=find(ReconstructedSlices.cube<0); 
ReconstructedSlices.cube(Negativeindicies)=0; 
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%set up variables to be matrices of size radii by angle, for ease of 
output 
Average=zeros(num_radii,num_radian); 
PixelCount=zeros(num_radii,num_radian); 
Sum=zeros(num_radii,num_radian); 
  
for radiusloop = 1:num_radii  
  for radianloop=1:num_radian 
     
    %define reff in terms of (r, theta) 
    reff = radius(radiusloop) * sin(thetaradians(radianloop)); 
  
    %calculate delta z from center z coordinate for each reff 
    deltaz = radius(radiusloop) * cos(thetaradians(radianloop)); 
     
    %apply delta z to center z coordinate correctly 
    zeff = cz + deltaz; 
     
    %define inner/outer effective radii 
    r = reff - delta;  
    R = reff + delta;  
  
    %define z planes to look at. +/-1 seemed like a better choice  
    zsmall=round(zeff-1); 
    zbig=round(zeff+1); 
      
    %search for pixels within annulus then adds them up for statistics 
analysis 
    %also computes average value at pixel (sum) for OD/DOSE output 
    %borrowed from slade's phoenixfire code 
    for z=max(1,zsmall):min(zmax,zbig) %so doesn't go outside cube 
coordinates 
        for x=1:xmax 
            for y=1:ymax 
                if ((r<(sqrt((cx-x)^2 + (cy-y)^2))) && (sqrt((cx-x)^2 + 
(cy-y)^2))<R) 
                   Sum(radiusloop,radianloop)=Sum(radiusloop,radianloop) + 
ReconstructedSlices.cube(x,y,z); 
                   
PixelCount(radiusloop,radianloop)=PixelCount(radiusloop,radianloop)+1; 
                end 
            end 
        end 
    end 
    Average(radiusloop, 
radianloop)=Sum(radiusloop,radianloop)/PixelCount(radiusloop,radianloop);  
  end  
end 
  
%this section exports my data to an excel file 
%asks where you want to save the excel file, and what to call it 
[fileName, pathName]=uiputfile('*.xlsx','Export Profile'); 
%assembling arrays into matrices x 2 
dataradius=num2cell(radius'); 
title={'Radius/Angle'}; 
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radiusdata=cat(1,title,dataradius); 
avgdata=num2cell([theta; Average]);  
countdata=num2cell([theta; PixelCount]); 
data1=cat(2,radiusdata,avgdata); 
data2=cat(2,radiusdata,countdata); 
%writes to the designated file & sheet# the 2 matrices i created above 
sheet=1; 
xlswrite(fullfile(pathName,fileName),data1,sheet); 
sheet=2; 
xlswrite(fullfile(pathName,fileName),data2,sheet); 
 
Appendix C 
Radial Dose Function Comparison Data for the Average of all four dosimeters. 
r (cm) 
Rivard 
et al. 
values 
PRESAGE 
values 
Standard 
Deviation 
COV 
(%) 
Percent 
Error 
1 1 1 0 0 0 
1.2 0.920 1.022 0.354 34.6 11.1 
1.4 0.848 1.091 0.564 51.7 28.6 
1.6 0.786 1.000 0.656 65.6 27.2 
1.8 0.732 0.831 0.614 73.9 13.5 
2 0.683 0.688 0.501 72.8 0.7 
3 0.511 0.191 0.187 98.0 62.6 
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